AustralieFrV1, Main, Exploration, bibRecord, 004D16

Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database

Identifieur interne : 004D16 ( Main/Exploration ); précédent : 004D15; suivant : 004D17

Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database

Auteurs : Günther Metz [Suisse] ; Nicholas Coppard [Suisse] ; Jonathon M. Cooper [Royaume-Uni] ; Martin B. Delatycki [Australie] ; Alexandra Dürr [France] ; Nicholas A. Di Prospero [États-Unis] ; Paola Giunti [Royaume-Uni] ; David R. Lynch [États-Unis] ; J. B. Schulz [Allemagne] ; Christian Rummey [Suisse] ; Thomas Meier [Suisse]

Source :

Brain [ 0006-8950 ] ; 2013.

RBID : Pascal:13-0208679

Descripteurs français

Pascal (Inist)
- Hérédodégénérescence spinocérébelleuse de Friedreich, Ataxie, Pathologie du système nerveux, Echelle d'évaluation, Homme, Base de données.
Wicri :
- topic : Homme, Base de données.

English descriptors

KwdEn :
- Ataxia, Database, Evaluation scale, Friedreich ataxia, Human, Nervous system diseases.

Abstract

The aim of this cross-sectional study was to analyse disease progression in Friedreich's ataxia as measured by the International Cooperative Ataxia Rating Scale. Single ratings from 603 patients with Friedreich's ataxia were analysed as a function of disease duration, age of onset and GAA repeat lengths. The relative contribution of items and subscales to the total score was studied as a function of disease progression. In addition, the scaling properties were assessed using standard statistical measures. Average total scale progression per year depends on the age of disease onset, the time since diagnosis and the GAA repeat length. The age of onset inversely correlates with increased GAA repeat length. For patients with an age of onset ≤14 years associated with a longer repeat length, the average yearly rate of decline was 2.5 ± 0.18 points in the total International Cooperative Ataxia Rating Scale for the first 20 years of disease duration, whereas patients with a later onset progress more slowly (1.8 ± 0.27 points/year). Ceiling effects in posture, gait and lower limb scale items lead to a reduced sensitivity of the scale in the severely affected population with a total score of >60 points. Psychometric scaling analysis shows generally favourable properties for the total scale, but the subscale grouping could be improved. This cross-sectional study provides a detailed characterization of the International Cooperative Ataxia Rating Scale. The analysis further provides rates of change separated for patients with early and late disease onset, which is driven by the GAA repeat length. Differences in the subscale dynamics merit consideration in the design of future clinical trials applying this scale as a neurological assessment instrument in Friedreich's ataxia.

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624678

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database</title>
<author><name sortKey="Metz, Gunther" sort="Metz, Gunther" uniqKey="Metz G" first="Günther" last="Metz">Günther Metz</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Santhera Pharmaceuticals</s1>
<s2>Liestal</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
<wicri:noRegion>Santhera Pharmaceuticals</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Coppard, Nicholas" sort="Coppard, Nicholas" uniqKey="Coppard N" first="Nicholas" last="Coppard">Nicholas Coppard</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Santhera Pharmaceuticals</s1>
<s2>Liestal</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
<wicri:noRegion>Santhera Pharmaceuticals</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cooper, Jonathon M" sort="Cooper, Jonathon M" uniqKey="Cooper J" first="Jonathon M." last="Cooper">Jonathon M. Cooper</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Department of Clinical Neurosciences, UCL Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Delatycki, Martin B" sort="Delatycki, Martin B" uniqKey="Delatycki M" first="Martin B." last="Delatycki">Martin B. Delatycki</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Bruce Lefroy Centre for Genetic Health Research, Murdoch Children's Research Institute</s1>
<s2>Parkville, Victoria</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Parkville, Victoria</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Durr, Alexandra" sort="Durr, Alexandra" uniqKey="Durr A" first="Alexandra" last="Dürr">Alexandra Dürr</name>
<affiliation wicri:level="3"><inist:fA14 i1="04"><s1>Department of Genetics and Cytogenetics, Pitié-Salpêtrière Hospital</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><inist:fA14 i1="05"><s1>INSERM U975, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Di Prospero, Nicholas A" sort="Di Prospero, Nicholas A" uniqKey="Di Prospero N" first="Nicholas A." last="Di Prospero">Nicholas A. Di Prospero</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Neurogenetics Branch, NINDS, NIH</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda, MD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Giunti, Paola" sort="Giunti, Paola" uniqKey="Giunti P" first="Paola" last="Giunti">Paola Giunti</name>
<affiliation wicri:level="3"><inist:fA14 i1="07"><s1>Department of Molecular Neuroscience, UCL Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lynch, David R" sort="Lynch, David R" uniqKey="Lynch D" first="David R." last="Lynch">David R. Lynch</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Division of Neurology, The Children's Hospital of Philadelphia</s1>
<s2>Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Philadelphia, PA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schulz, J B" sort="Schulz, J B" uniqKey="Schulz J" first="J. B." last="Schulz">J. B. Schulz</name>
<affiliation wicri:level="3"><inist:fA14 i1="09"><s1>Department of Neurology, University Hospital, RWTH Aachen and JARA-Brain</s1>
<s2>Aachen</s2>
<s3>DEU</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region>
<region type="district" nuts="2">District de Cologne</region>
<settlement type="city">Aix-la-Chapelle</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rummey, Christian" sort="Rummey, Christian" uniqKey="Rummey C" first="Christian" last="Rummey">Christian Rummey</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Pharma</s1>
<s2>Liestal</s2>
<s3>CHE</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
<wicri:noRegion>Pharma</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Meier, Thomas" sort="Meier, Thomas" uniqKey="Meier T" first="Thomas" last="Meier">Thomas Meier</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Santhera Pharmaceuticals</s1>
<s2>Liestal</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
<wicri:noRegion>Santhera Pharmaceuticals</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">13-0208679</idno>
<date when="2013">2013</date>
<idno type="stanalyst">PASCAL 13-0208679 INIST</idno>
<idno type="RBID">Pascal:13-0208679</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000A13</idno>
<idno type="wicri:Area/PascalFrancis/Curation">005463</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000690</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000690</idno>
<idno type="wicri:doubleKey">0006-8950:2013:Metz G:rating:disease:progression</idno>
<idno type="wicri:Area/Main/Merge">004E64</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3624678</idno>
<idno type="RBID">PMC:3624678</idno>
<idno type="wicri:Area/Pmc/Corpus">000177</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000177</idno>
<idno type="wicri:Area/Pmc/Curation">000177</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000177</idno>
<idno type="wicri:Area/Pmc/Checkpoint">001918</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">001918</idno>
<idno type="wicri:Area/Ncbi/Merge">001116</idno>
<idno type="wicri:Area/Ncbi/Curation">001116</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001116</idno>
<idno type="wicri:doubleKey">0006-8950:2013:Metz G:rating:disease:progression</idno>
<idno type="wicri:Area/Main/Merge">004607</idno>
<idno type="wicri:Area/Main/Curation">004D16</idno>
<idno type="wicri:Area/Main/Exploration">004D16</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database</title>
<author><name sortKey="Metz, Gunther" sort="Metz, Gunther" uniqKey="Metz G" first="Günther" last="Metz">Günther Metz</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Santhera Pharmaceuticals</s1>
<s2>Liestal</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
<wicri:noRegion>Santhera Pharmaceuticals</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Coppard, Nicholas" sort="Coppard, Nicholas" uniqKey="Coppard N" first="Nicholas" last="Coppard">Nicholas Coppard</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Santhera Pharmaceuticals</s1>
<s2>Liestal</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
<wicri:noRegion>Santhera Pharmaceuticals</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Cooper, Jonathon M" sort="Cooper, Jonathon M" uniqKey="Cooper J" first="Jonathon M." last="Cooper">Jonathon M. Cooper</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Department of Clinical Neurosciences, UCL Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Delatycki, Martin B" sort="Delatycki, Martin B" uniqKey="Delatycki M" first="Martin B." last="Delatycki">Martin B. Delatycki</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Bruce Lefroy Centre for Genetic Health Research, Murdoch Children's Research Institute</s1>
<s2>Parkville, Victoria</s2>
<s3>AUS</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Parkville, Victoria</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Durr, Alexandra" sort="Durr, Alexandra" uniqKey="Durr A" first="Alexandra" last="Dürr">Alexandra Dürr</name>
<affiliation wicri:level="3"><inist:fA14 i1="04"><s1>Department of Genetics and Cytogenetics, Pitié-Salpêtrière Hospital</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3"><inist:fA14 i1="05"><s1>INSERM U975, Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region">Île-de-France</region>
<region type="old region">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Di Prospero, Nicholas A" sort="Di Prospero, Nicholas A" uniqKey="Di Prospero N" first="Nicholas A." last="Di Prospero">Nicholas A. Di Prospero</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Neurogenetics Branch, NINDS, NIH</s1>
<s2>Bethesda, MD</s2>
<s3>USA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Bethesda, MD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Giunti, Paola" sort="Giunti, Paola" uniqKey="Giunti P" first="Paola" last="Giunti">Paola Giunti</name>
<affiliation wicri:level="3"><inist:fA14 i1="07"><s1>Department of Molecular Neuroscience, UCL Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<placeName><settlement type="city">Londres</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Grand Londres</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Lynch, David R" sort="Lynch, David R" uniqKey="Lynch D" first="David R." last="Lynch">David R. Lynch</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Division of Neurology, The Children's Hospital of Philadelphia</s1>
<s2>Philadelphia, PA</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>Philadelphia, PA</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schulz, J B" sort="Schulz, J B" uniqKey="Schulz J" first="J. B." last="Schulz">J. B. Schulz</name>
<affiliation wicri:level="3"><inist:fA14 i1="09"><s1>Department of Neurology, University Hospital, RWTH Aachen and JARA-Brain</s1>
<s2>Aachen</s2>
<s3>DEU</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName><region type="land" nuts="1">Rhénanie-du-Nord-Westphalie</region>
<region type="district" nuts="2">District de Cologne</region>
<settlement type="city">Aix-la-Chapelle</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Rummey, Christian" sort="Rummey, Christian" uniqKey="Rummey C" first="Christian" last="Rummey">Christian Rummey</name>
<affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Pharma</s1>
<s2>Liestal</s2>
<s3>CHE</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
<wicri:noRegion>Pharma</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Meier, Thomas" sort="Meier, Thomas" uniqKey="Meier T" first="Thomas" last="Meier">Thomas Meier</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Santhera Pharmaceuticals</s1>
<s2>Liestal</s2>
<s3>CHE</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Suisse</country>
<wicri:noRegion>Santhera Pharmaceuticals</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Brain</title>
<title level="j" type="abbreviated">Brain</title>
<idno type="ISSN">0006-8950</idno>
<imprint><date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Brain</title>
<title level="j" type="abbreviated">Brain</title>
<idno type="ISSN">0006-8950</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Ataxia</term>
<term>Database</term>
<term>Evaluation scale</term>
<term>Friedreich ataxia</term>
<term>Human</term>
<term>Nervous system diseases</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Hérédodégénérescence spinocérébelleuse de Friedreich</term>
<term>Ataxie</term>
<term>Pathologie du   système nerveux</term>
<term>Echelle d'évaluation</term>
<term>Homme</term>
<term>Base de données</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
<term>Base de données</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The aim of this cross-sectional study was to analyse disease progression in Friedreich's ataxia as measured by the International Cooperative Ataxia Rating Scale. Single ratings from 603 patients with Friedreich's ataxia were analysed as a function of disease duration, age of onset and GAA repeat lengths. The relative contribution of items and subscales to the total score was studied as a function of disease progression. In addition, the scaling properties were assessed using standard statistical measures. Average total scale progression per year depends on the age of disease onset, the time since diagnosis and the GAA repeat length. The age of onset inversely correlates with increased GAA repeat length. For patients with an age of onset ≤14 years associated with a longer repeat length, the average yearly rate of decline was 2.5 ± 0.18 points in the total International Cooperative Ataxia Rating Scale for the first 20 years of disease duration, whereas patients with a later onset progress more slowly (1.8 ± 0.27 points/year). Ceiling effects in posture, gait and lower limb scale items lead to a reduced sensitivity of the scale in the severely affected population with a total score of >60 points. Psychometric scaling analysis shows generally favourable properties for the total scale, but the subscale grouping could be improved. This cross-sectional study provides a detailed characterization of the International Cooperative Ataxia Rating Scale. The analysis further provides rates of change separated for patients with early and late disease onset, which is driven by the GAA repeat length. Differences in the subscale dynamics merit consideration in the design of future clinical trials applying this scale as a neurological assessment instrument in Friedreich's ataxia.</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
<li>Australie</li>
<li>France</li>
<li>Royaume-Uni</li>
<li>Suisse</li>
<li>États-Unis</li>
</country>
<region><li>Angleterre</li>
<li>District de Cologne</li>
<li>Grand Londres</li>
<li>Rhénanie-du-Nord-Westphalie</li>
<li>Île-de-France</li>
</region>
<settlement><li>Aix-la-Chapelle</li>
<li>Londres</li>
<li>Paris</li>
</settlement>
</list>
<tree><country name="Suisse"><noRegion><name sortKey="Metz, Gunther" sort="Metz, Gunther" uniqKey="Metz G" first="Günther" last="Metz">Günther Metz</name>
</noRegion>
<name sortKey="Coppard, Nicholas" sort="Coppard, Nicholas" uniqKey="Coppard N" first="Nicholas" last="Coppard">Nicholas Coppard</name>
<name sortKey="Meier, Thomas" sort="Meier, Thomas" uniqKey="Meier T" first="Thomas" last="Meier">Thomas Meier</name>
<name sortKey="Rummey, Christian" sort="Rummey, Christian" uniqKey="Rummey C" first="Christian" last="Rummey">Christian Rummey</name>
</country>
<country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Cooper, Jonathon M" sort="Cooper, Jonathon M" uniqKey="Cooper J" first="Jonathon M." last="Cooper">Jonathon M. Cooper</name>
</region>
<name sortKey="Giunti, Paola" sort="Giunti, Paola" uniqKey="Giunti P" first="Paola" last="Giunti">Paola Giunti</name>
</country>
<country name="Australie"><noRegion><name sortKey="Delatycki, Martin B" sort="Delatycki, Martin B" uniqKey="Delatycki M" first="Martin B." last="Delatycki">Martin B. Delatycki</name>
</noRegion>
</country>
<country name="France"><region name="Île-de-France"><name sortKey="Durr, Alexandra" sort="Durr, Alexandra" uniqKey="Durr A" first="Alexandra" last="Dürr">Alexandra Dürr</name>
</region>
<name sortKey="Durr, Alexandra" sort="Durr, Alexandra" uniqKey="Durr A" first="Alexandra" last="Dürr">Alexandra Dürr</name>
</country>
<country name="États-Unis"><noRegion><name sortKey="Di Prospero, Nicholas A" sort="Di Prospero, Nicholas A" uniqKey="Di Prospero N" first="Nicholas A." last="Di Prospero">Nicholas A. Di Prospero</name>
</noRegion>
<name sortKey="Lynch, David R" sort="Lynch, David R" uniqKey="Lynch D" first="David R." last="Lynch">David R. Lynch</name>
</country>
<country name="Allemagne"><region name="Rhénanie-du-Nord-Westphalie"><name sortKey="Schulz, J B" sort="Schulz, J B" uniqKey="Schulz J" first="J. B." last="Schulz">J. B. Schulz</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004D16 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004D16 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:13-0208679
   |texte=   Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database
}}

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

Serveur d'exploration sur les relations entre la France et l'Australie

Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database

Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.